News
The U.S. Food and Drug Administration on Monday warned consumers and pharmacies that fake versions of Ozempic, a drug to ...
4d
MedPage Today on MSNDiabetes, Heart Disease Drugs Recalled; New Trump Order; Maple Syrup's Health ClaimsThe Trump administration exempted nearly 70 coal plants from a Biden-era rule that aimed to reduce emissions of mercury and ...
Older adults living with Type 2 diabetes face more than just blood sugar concerns. New research shows some of the most ...
Research shows diabetes medications may cut Alzheimer's risk by up to 43% in patients with type 2 diabetes, offering ...
Even the solid proposals set out by the Trump administration are being undermined by its actions taken elsewhere.
People diagnosed with type 2 diabetes might benefit soon from Eli Lilly's new orforglipron weight loss drug following its ...
A certain class of diabetes drug has been linked to a significant reduction in dementia risk. | Health And Medicine ...
“Most endocrinologists nowadays do understand that people with type 1 diabetes – not everyone, but some, would benefit” from ...
A daily pill from drugmaker Eli Lilly has shown safety results comparable to the leading injectable GLP-1 drugs Mounjaro and ...
A study led by two undergraduate students at the University of Galway found that GLP-1 receptor agonists, a type of diabetes ...
Two undergraduate medicine students have led a major study examining how cardioprotective glucose-lowering therapies -- medications that lower blood sugar and reduce the risk of heart disease in ...
2d
Verywell Health on MSNDaily GLP-1 Pill Shows Promise for Diabetes and Weight Loss, Eli Lilly SaysA new drug, called orforglipron, can help people with diabetes manage their A1C and weight, according to topline results from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results